Non-HFE hemochromatosis: Pathophysiological and diagnostic aspects. - Archive ouverte HAL Access content directly
Journal Articles Clinics and Research in Hepatology and Gastroenterology Year : 2013

Non-HFE hemochromatosis: Pathophysiological and diagnostic aspects.

(1) , (2, 3) , (2, 4) , (1) , (2, 4) , (1)
1
2
3
4

Abstract

Rare genetic iron overload diseases are an evolving field due to major advances in genetics and molecular biology. Genetic iron overload has long been confined to the classical type 1 hemochromatosis related to the HFE C282Y mutation. Breakthroughs in the understanding of iron metabolism biology and molecular mechanisms led to the discovery of new genes and subsequently, new types of hemochromatosis. To date, four types of hemochromatosis have been identified: HFE-related or type1 hemochromatosis, the most frequent form in Caucasians, and four rare types, named type 2 (A and B) hemochromatosis (juvenile hemochromatosis due to hemojuvelin and hepcidin mutation), type 3 hemochromatosis (related to transferrin receptor 2 mutation), and type 4 (A and B) hemochromatosis (ferroportin disease). The diagnosis relies on the comprehension of the involved physiological defect that can now be explored by biological and imaging tools, which allow non-invasive assessment of iron metabolism. A multidisciplinary approach is essential to support the physicians in the diagnosis and management of those rare diseases.
Fichier principal
Vignette du fichier
Hemochromatosis_CRHG-accepted.pdf (267.48 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-00925741 , version 1 (08-01-2014)

Identifiers

Cite

Edouard Bardou-Jacquet, Zeineb Ben Ali, Marie-Pascale Beaumont-Epinette, Olivier Loréal, Anne-Marie Jouanolle, et al.. Non-HFE hemochromatosis: Pathophysiological and diagnostic aspects.. Clinics and Research in Hepatology and Gastroenterology, 2013, 38 (2), pp.143-154. ⟨10.1016/j.clinre.2013.11.003⟩. ⟨hal-00925741⟩
1347 View
1231 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More